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BRC Criteria Revised
Donna Shalala, secretary of the
Department of Health and
Human Services, has approved a
revision of the criteria for listing
a substance in the Biennial Report '-/
on Carcinogens (BRC) as "reasonably
anticipated to be a human carcinogen."
After formally approving the revised criteria,
Secretary Shalala said, 'The revisions will
benefit public health-you and me-
because [they] allow the use of information
generated utilizing recent advances ofbiolo-
gy at the level ofthe gene and living cell to
aid in thehazard identification process."
The majorchange in the BRC is that the
National Toxicology Program (NTP), head-
quartered at the NIEHS, will consider all
relevant information-including mechanis-
tic data-in determining whether to list a
substance. These revisions also allow for
removal ofsubstances from the BRC when
newinformation becomes available.
Relevant information indudes, but is not
limited to, dose response, route ofexposure,
chemical structure, metabolism, pharmacoki-
netics, sensitive subpopulations, genetic
effects, other data relating to mechanism of
action, or factors that may be unique to a
given substance. The last factor is especially
important for the "reasonably anticipated to
be a human carcinogen" category, where
there may not be available evidence of car-
cinogenicity in humans or traditional labora-
VINTI
tory studies using rats and mice,
but where there is convincing rele-
vant information that the agent
acts through mechanisms indicat-
ing it would likely cause cancer in
cQ" humans. Conversely, there may be a
substance for which there is evidence of
carcinogenicity in laboratory rodents but
compelling data indicating that the agent acts
through mechanisms that do not operate in
humans and that would therefore reasonably
beanticipated notto cause cancer inhumans.
Most substances listed in the BRC are
contained in the "reasonably anticipated to
be a human carcinogen" category based on
studies performed on laboratory animals and
linked to an increased incidence of malig-
nant tumors. The categorization may also be
based on a combination of malignant and
benign tumors in two or more animal
species, or in two or more studies, or the
occurence ofcancers ofparticularly unusual
types or at sites that do not normally occur
in the animals studied.
The revised criteria for listing a sub-
stance as "known to be a human carcino-
gen" are substantively unchanged from the
former criteria, although the wording was
slightly altered. To be listed as a known
human carcinogen there must be "sufficient
evidence of carcinogenicity from studies in
humans that indicates a causal relationship
between exposure to the agent, substance, or
mixture and human cancer."
The public process for the review of
listing criteria included participation or
input from a broad base ofinterested par-
ties from academia, industry, labor, feder-
al, state, and local health agencies, and pri-
vate organizations. The review included
two public meetings by the NTP Board of
Scientific Counselors, several reviews by
the NTP Executive Committee, and a
review by the Public Health Service's
Environmental Health Policy Committee.
An expanded, formal review procedure
for the inclusion or removal ofsubstances
in the BRC has also been established. This
expanded procedure adds another compre-
hensive peer review step to this process
with the establishment of a new standing
subcommittee of the NTP Board of
Scientific Counselors to provide outside
peer review. Anyone may nominate a sub-
stance to be considered for listing or delist-
ing in the BRC. All petitions received will
undergo the expanded review process
including reviews by NTP staff and NTP
Executive Committee scientists as well as a
review by the NTP Board of Scientific
Counselors Subcommittee for the BRC,
which will be held in public meetings.
Kenneth Olden, director of both the
NTP and the NIEHS, said, "It makes good
sense to fine-tune the process so that newly
relevant scientific data is considered."
Biennial Report On Carcinogens
Listing/Delisting Procedure
Petitions for listing or defisting an agent, substance, or mixture in the BRC may be
submitted by any interested party and should be sent to the National Toxicology
Program, Biennial Report on Carcinogens, MD WC-05, P.O. Box 12233, Research
Triangle Park, NC 27709. Petitions must contain an explanation for listing or delist-
ing the agent, substance, or mixture in the BRC as either a known human carcinogen
or a reasonably anticipated human carcinogen. To the extent feasible, all appropriate
background information and relevant data (e.g., scientific journal publications, NTP
reports, IARC listings, exposure surveys, release inventories, etc.) that support the peti-
tion should be provided or fully referenced to permit retrieval. Petitions will be
reviewed as expeditiously as possible. A list of new petitions for listing or delisting,
which solicits public comment and input on the petitions, will be routinely published
in appropriate publications, induding the FederalRegister, trade journals, and NTP
Liaison office mail-outs.
Each petition received will be evaluated by a formal procedure that indudes initial
review by an NIEHS/NTP Review Group made up of senior scientists of the
NIEHS/NTP staff, followed by consideration by the NTP Executive Committee's
Working Group for the Biennial Report on Carcinogens and also by a standing NTP
BoardofScientific Counselors Subcommittee for the BRC inpublic session. Adetailed
procedures document outlining the steps ofa petition review can be obtained by con-
tacting the NTP Liaison Office, NIEHS, P.O. Box 12233, Research Triangle Park,
NC 27709.
ERRATUM
In the article entitled Sciencefrom the
Sea in the May 1996 issue of EHP,
James L. Boyer, director of the Mount
Desert Island Biological Laboratory's
Center for Membrane Toxicity Studies,
was mistakenly identified under a pho-
tograph of David Evans. EHP regrets
the error. Dr. Boyer ispictured below.
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